Cost analysis of combining congenital cardiac catheterization and electrophysiology procedures in an outpatient setting

Abstract

Combining cath and EP outpatient procedures reduces the time commitment and provides some economic advantage.

Efficacy and Safety in Combining Primary Palatoplasty and Myringotomy in Patients with Cleft Palate

“… 28 The decrease in health care cost of concurrent procedures compared to consecutive procedures was also determined in a retrospective study conducted by Stapleton et al 29 that focused on the financial and temporal differences between separate and combined dental and medical procedures. Bansal et al 11 studied the cost-effectiveness of combining cardiac catheterization with electrophysiology in pediatric patients and reported a shorter recovery time, shorter LOS, and an average reduction in costs in combined procedures. In adults with congenital heart disease, Lindsay et al 12 noted shorter anesthesia usage, shorter hospital stays, and a 37% reduction in hospital charges among other decreased outcome measures when comparing combined and consecutive electrophysiologic and structural interventions.…”

“…While there have been studies supporting the potential benefits of combined procedures across different specialties, 11 , 12 , 27 – 31 the current study is the first, to our knowledge, that specifically examines the safety and efficacy of combining PP and BMT. Our study demonstrated statistically significant decreased time spent in the PACU and decreased dose administration of fentanyl in comparison to cases of separate procedures.…”

“…Recent literature in the cardiac field has reported shorter anesthesia, shorter procedure duration, and shorter length of stay (LOS). 11 , 12 In patients born with CLP, BMT and palatoplasty (PP) can be performed concomitantly, theoretically decreasing exposure to anesthesia. There is a paucity of plastic surgery literature objectively assessing the efficacy of performing concomitant surgeries with regards to such factors as surgical outcomes, morbidity, total operative time, LOS in the post-anesthetic care unit, and anesthesia dosages administered.…”

Combined hybrid pulmonary valve placement and atrial septal defect closure: case report and literature review

“…Recent studies have shown that combining procedures in patients with CHD is feasible, safe, and can reduce costs. 3,4 Transcatheter pulmonary valve implantation has revolutionised the non-surgical treatment of dysfunction right ventricular outflow tracts in the past two decades. 5,6 There are two valves currently approved by the U.S. Food and Drug Administration for use only in previously placed surgical conduits, the Melody valve (Medtronic, Minneapolis, MN), and the Edwards SAPIEN valve (Edwards Lifesciences, Irvine, CA).…”